
Sriniwas Pharmaceuticals Private Limited
About Sriniwas Pharmaceuticals Private Limited
Data last updated:
Sriniwas Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 08 August 2022.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24300GJ2022PTC134586.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mukesh Mohanka and Pawon Kumar Mohanka.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Shikha Mukesh Mohanka B 204 Hari Om Elegance Godhavi Sanand, Ahmedabad, Gujarat, India – 382115.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.29 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3,000 (net margin 0.2%) and EBITDA of ₹13,010 (EBITDA margin 1%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sriniwas Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat.
- Registered AddressC/O Shikha Mukesh Mohanka B 204 Hari Om Elegance Godhavi Sanand, Ahmedabad, Gujarat, India – 382115
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sriniwas Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sriniwas Pharmaceuticals Private Limited, buy the company report.
Financials of Sriniwas Pharmaceuticals Private Limited
FY 2024 filings availableSriniwas Pharmaceuticals Private Limited reported revenue of ₹13.29 Lakh (up 263% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 263% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹13,010 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹3,000 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1% | |
| Net Profit Margin | 0.2% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Sriniwas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sriniwas Pharmaceuticals Private Limited
Sriniwas Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Mohanka | Director | 08 Aug 2022 | 4 Years 3 Months | Current |
| Pawon Kumar Mohanka | Director | 11 Mar 2023 | 3 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Sriniwas Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sriniwas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sriniwas Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sriniwas Pharmaceuticals Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Anurag Jain ceased to be Director on 11 Mar 2023.
Frequently asked questions
Sriniwas Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 08 August 2022 (4+ years old) and is registered under CIN U24300GJ2022PTC134586.
Sriniwas Pharmaceuticals has 2 current directors:
- Mukesh Mohanka - Director
- Pawon Kumar Mohanka - Director
The latest financial statements of Sriniwas Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Sriniwas Pharmaceuticals is U24300GJ2022PTC134586. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sriniwas Pharmaceuticals was incorporated on 08 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Anurag Jain ceased to be Director on 11 Mar 2023. Pawon Kumar Mohanka was appointed as Director on 11 Mar 2023. Anurag Jain was appointed as Director on 08 Aug 2022. Sriniwas Pharmaceuticals has 4 board changes on record in total.
The registered office of Sriniwas Pharmaceuticals is at CO Shikha Mukesh Mohanka B 204 Hari Om Elegance Godhavi Sanand, Ahmedabad, Gujarat, India – 382115.
Sriniwas Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.
The compliance status of Sriniwas Pharmaceuticals is compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.
Sriniwas Pharmaceuticals can be reached at its registered office: CO Shikha Mukesh Mohanka B 204 Hari Om Elegance Godhavi Sanand, Ahmedabad, Gujarat, India – 382115.

